In 2020, Chernock et al. [13] described six high-grade carcinomas that meet the World Health Organization (WHO) criteria [1] for the definition of PDTC in patients ≤ 21 years of age and found hotspot somatic pathogenic variants of DICER1 in five of them. The gene discussed is DICER1; the disease is carcinoma.